PYRAZOLE-THIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASES
申请人:Agouron Pharmaceuticals, Inc.
公开号:EP1307462A2
公开(公告)日:2003-05-07
US6566363B2
申请人:——
公开号:US6566363B2
公开(公告)日:2003-05-20
[EN] PYRAZOLE-THIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS OF THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASES<br/>[FR] COMPOSES PYRAZOLE-THIAZOLE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, ET LEURS PROCEDES D'UTILISATION POUR INHIBER LES KINASES CYCLINO-DEPENDANTES
申请人:AGOURON PHARMA
公开号:WO2002012250A2
公开(公告)日:2002-02-14
Pyrazole-thiazole compounds that modulate and/or inhibit the activity of cyclin-dependent kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating cyclin-dependent diseases to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
FACILE SYNTHESIS OF FLUORINATED 2-ARYL-5,7 BISALKYL PYRAZOLO PYRIMIDINES FROM ARYLALKYNE NITRILES†
Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
申请人:——
公开号:US20020049215A1
公开(公告)日:2002-04-25
Pyrazole-thiazole compounds that modulate and/or inhibit the activity of cyclin-dependent kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating cyclin-dependent diseases to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.